Drug Shortage Report for RAN-ROPINIROLE
Report ID | 152163 |
Drug Identification Number | 02314053 |
Brand name | RAN-ROPINIROLE |
Common or Proper name | ROPINIROLE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ROPINIROLE |
Strength(s) | 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N04BC |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-12-30 |
Estimated end date | 2022-01-07 |
Actual end date | 2022-01-21 |
Shortage status | Resolved |
Updated date | 2022-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-02-15 | French | Compare |
v3 | 2022-02-15 | English | Compare |
v2 | 2022-01-06 | French | Compare |
v1 | 2022-01-06 | English | Compare |
Showing 1 to 4 of 4